SPDR S&P PHARMA ETF Blog | Talkmarkets | Page 2
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
Q2 Earnings Drive Pharma ETFs Higher
Article By: Sweta Killa
Tuesday, August 7, 2018 12:23 PM EDT
Total earnings for 83.5% of the total healthcare market capitalization are up 13.7% on revenue growth of 7.8%.
In this article: IHE, PJP, PPH, XPH, FTXH Also: BMY, JNJ, LLY, MRK, PFE
Read
Biotech Year One: A Year Of Trials Tribulations And Discovery
Article By: Kieran O'Dea
Monday, December 25, 2017 8:24 AM EDT
The biotech market is its own beast, derived from the aggregate opinions and knowledge of the mainstream thought. The market has a binary, linear, and simplistic approach to trial results ignoring the context in which each trial is conducted.
In this article: IBB, XBI, XPH, SPY, TEVA, AGN, JNJ, MYL, BMY, BIIB, PFE, MRK, INCY
Read
Pharma ETFs Down Post Q3 Earnings
Article By: Sweta Killa
Thursday, November 9, 2017 4:19 PM EDT
The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.
In this article: PJP, IHE, XPH, PPH Also: JNJ, LLY, PFE, MRK, BMY
Read
Q2 Earnings Fail To Impress Pharma ETF
Article By: Sweta Killa
Monday, August 7, 2017 4:47 PM EDT
Total earnings for 83.3% of the total healthcare market capitalization are up 6% on revenue growth of 4.1%.
In this article: IHE, PJP, XPH, PPH Also: BMY, JNJ, LLY, MRK, PFE
Read
End-Of-Week Sentiment And Trends
Article By: Douglas Gammons
Saturday, April 8, 2017 8:35 AM EDT
It seems as though if you wait for price to confirm then a big portion of the short-term has already been made.
In this article: EWY, XLB, XPH Also: RSX
Read

PARTNER HEADLINES

Latest Tweets for $XPH

No tweets yet!